Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma

Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma

<p dir="ltr">Advanced hepatocellular carcinoma (HCC) is a serious condition associated with significant morbidity and mortality. Over the past few decades, however, this has drastically changed, primarily attributed to the development of new treatments, including tyrosine-kinase inhi...

Full description

Saved in:
Bibliographic Details
Main Author: Nabil E. Omar (9545756) (author)
Other Authors: Hazem Elewa (3592601) (author), Kareem A. El-Fass (9545759) (author), Dario Trapani (9279245) (author), Said Dermime (79420) (author), Daoud Al-Badriyeh (832403) (author), Dina Abushanab (10696501) (author), Anas Hamad (9545771) (author)
Published: 2025
Subjects:
Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
hepatocellular carcinoma
immune checkpoint inhibitors
low- and middle-income countries
financial toxicity
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items